Evaluación, diagnóstico y manejo de la distrofia muscular congénita

1. American Academy of Neurology. Clinical Practice Guidelines Process Manual, 2004 ed. St. Paul, MN: The American Academy of Neurology; 2004. Available at: https://www.aan.com/Guidelines/Home/Development. Accessed February 12, 2012. Published 2004.
2. American Academy of Neurology. Clinical Practice Guidelines Process Manual, 2011 ed. St. Paul, MN: The American Academy of Neurology; 2011. Available at: https://www.aan.com/Guidelines/Home/Development. Accessed February 12, 2012. Published August 2011.
3. Floriach-Robert M, Cabello A, Simon De Las Heras R, Mateos Beato F. Neonatal hypotonia of muscular origin: analysis of 50 cases [in Spanish]. Neurologia 2001; 16:245–253.
4. Mostacciuolo ML, Miorin M, Martinello F, Angelini C, Perini P, Trevisan CP. Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. nHum Genet 1996; 97:277–279.
5. Darin N, Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord 2000; 10:1–9.
6. Bönnemann CG, Wang CH, Quijano-Roy S, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord 2014; 24:289–311.
7. Bönnemann CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol 2011; 7:379–390.
8. Bönnemann CG. The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy. Handb Clin Neurol 2011; 101:81–96.
9. Fukuyama Y, Osawa M, Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type: clinical, genetic and pathological considerations. Brain Dev 1981; 3:1–29.
10. Manzini MC, Tambunan DE, Hill RS, et al. Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am J Hum Genet 2012; 91:541–547.
11. Vuillaumier-Barrot S, Bouchet-Séraphin C, Chelbi M, et al. Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly. Am J Hum Genet 2012; 91:1135–1143.
12. Stevens E, Carss KJ, Cirak S, et al. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of a-dystroglycan. Am J Hum Genet 2013; 92:354–365.
13. Jae LT, Raaben M, Riemersma M, et al. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science 2013; 340:479–483.
14. Buysse K, Riemersma M, Powell G, et al. Missense mutations in b-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. Hum Mol Genet 2013; 22:1746–1754.
15. Carss KJ, Stevens E, Foley AR, et al. Mutations in GDP mannose pyrophosphorylase B cause congenital and limbgirdle muscular dystrophies associated with hypoglycosylation of a-dystroglycan. Am J Hum Genet 2013; 93:29–41.
16. Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, et al. A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med 2011; 364:939–946.
17. Kato R, Kawamura J, Sugawara H, Niikawa N, Matsumoto N. A rapid diagnostic method for a retrotransposal insertional mutation into the FCMD gene in Japanese patients with Fukuyama congenital muscular dystrophy. Am J Med Genet A 2004; 127A:54–57.
18. Chang W, Winder TL, LeDuc CA, et al. Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenat Diagn 2009; 29:560–569.
19. Balci B, Uyanik G, Dincer P, et al. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul Disord 2005; 15:271–275.
20. Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995; 11:216–218.
21. Chae JH, Lee JS, Hwang H, et al.Merosin-deficient congenital muscular dystrophy in Korea. Brain Dev 2009; 31:341–346.
22. Lim BC, Ki CS, Kim JW, et al. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea. Neuromuscul Disord 2010; 20:524–530.
23. Camacho Vanegas O, Bertini E, Zhang RZ, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA 2001; 98:7516–7521.
24. Aparicio Meix JM, Pascual-Castroviejo I. Ullrich syndrome: a hypotonic disorder of early infancy, difficult to define as an entity. An Esp Pediatr 1980; 13:979–984.
25. Herrmann R, Straub V, Meyer K, Kahn T, Wagner M, Voit T. Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry. Eur J Pediatr 1996; 155:968–976.
26. Godfrey C, Clement E, Mein R, et al. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 2007; 130: 2725–2735.
27. Diesen C, Saarinen A, Pihko H, et al. POMGnT1 mutation and phenotypic spectrum in muscle-eye-brain disease. J Med Genet 2004; 41:e115.
28. Auranen M, Rapola J, Pihko H, et al. Muscle membraneskeleton protein changes and histopathological characterization of muscle-eye-brain disease. Neuromuscul Disord 2000;10:16–23.
29. Cotarelo RP, Fano O, Raducu M, et al. A double homozygous mutation in the POMT1 gene involving exon skipping gives rise to Walker-Warburg syndrome in two Spanish Gypsy families. Clin Genet 2009; 76:108–112.
30. Menezes MP, Waddell LB, Evesson FJ, et al. Importance and challenge of making an early diagnosis in LMNA-related muscular dystrophy. Neurology 2012; 78:1258–1263.
31. Lamer S, Carlier RY, Pinard JM, et al. Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency. Radiology 1998; 206:811–816.
32. Aida N, Yagishita A, Takada K, Katsumata Y. Cerebellar MR in Fukuyama congenital muscular dystrophy: polymicrogyria with cystic lesions. AJNR Am J Neuroradiol 1994; 15:1755–1759.
33. Bindu PS, Gayathri N, Bharath RD, Mahadevan A, Sinha S, Taly AB. Pattern recognition on brain magnetic resonance imaging in alpha dystroglycanopathies. Neurol India 2010; 58:460–465.
34. Brockmann K, Becker P, Schreiber G, Neubert K, Brunner E, Bönnemann C. Sensitivity and specificity of qualitative muscle ultrasound in assessment of suspected neuromuscular disease in childhood. Neuromuscul Disord 2007; 17:517–523.
35. Aydinli N, Baslo B, Caliskan M, Ertas M, Ozmen M. Muscle ultrasonography and electromyography correlation for evaluation of floppy infants. Brain Dev 2003; 25:22–24.
36. Mercuri E, Clements E, Offiah A, et al. Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol 2010; 67: 201–208.
37. Deconinck N, Dion E, Ben Yaou R, et al. Differentiating Emery-Dreifuss muscular dystrophy and collagen VI-related myopathies using a specific CT scanner pattern. Neuromuscul Disord 2010; 20:517–523.
38. Hayashi YK, Koga R, Tsukahara T, et al. Deficiency of laminin alpha 2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve 1995; 18:1027–1030.
39. Ferreira LG, Marie SK, Liu EC, et al. Dystrophin-glycoproteins associated in congenital muscular dystrophy: immunohistochemical analysis of 59 Brazilian cases. Arq Neuropsiquiatr 2005; 63:791–800.
40. Geranmayeh F, Clement E, Feng LH, et al. Genotype phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord 2010; 20:241–250.